SlideShare a Scribd company logo
INTRODUCTION TO
PHARMACOTHERAPEUTI
CS
By: Mr. Kiran B. Dhamak
Learning Objectives
 After studying the chapter, students will be able to
 Understand the concept of Pharmacotherapeutics
 Explain rational use of medicine
 Understand the concept of evidence based
medicine
 Use essential medicines list
 Understand the concept of standard treatment
guidelines
 Assess their knowledge and understand the
chapter through practice questions
Introduction
 Pharmacotherapeutics is a branch of
Pharmacology.
 It is the study of therapeutic uses and effects of
drugs.
 It is the application of pharmacological information
of drugs to prevent mitigate treat and diagnose
diseases as well as to change normal functions
(such as contraception).
 It includes determination of therapeutic objectives
selection of the most appropriate drug, route of
administration, dosage and duration of treatment
considering.
Pharmacotherapeutics is the study of
therapeutic uses and effects of drugs.
 Stage of disease
 The patient's current drugs
 Pharmacokinetics of drugs
 Contraindications
 Adverse effects of drugs
 The specific features of a patient
 Only Rational Pharmacotherapy brings good
treatment results.
 Rational pharmacotherapy means that medications
are prescribed sensibly delivered correctly and that
the patient is given the required information about
taking them.
 Knowledge of pharmacotherapy is essential to
practice medicine.
 Appropriate pharmacotherapy helps patients to
maintain their functional capacity and reduce the costs
to both patients and society.
 The other forms of therapies to treat diseases are
surgical therapy, physical therapy, radiation therapy,
etc
Scope
 The study of Pharmacotherapeutics imparts
knowledge and skills necessary to contribution to
quality use of medicines.
 Pharmacotherapy focuses on the relationship
between drugs and their safe and efficient use to
humans.
 It ensures proper and rational use of drugs.
 Determination of therapeutic objectives, selection
of the most appropriate drug dosage and duration
of treatment considering the stage of disease and
the specific feature of a patient are a part of
pharmacotherapeutics
Objectives
 The main objective of pharmacotherapeutics is to
enhance the safety of prescription maximize the
effects of drugs and to minimize side effects.
 To prepare individualized therapeutic plans based
on diagnosis
 To achieve defined therapeutic goals to improve a
patient's quality of life while minimizing harm.
 To maintain drug therapy costs at an optimum
level and still provide quality and effective
treatment
 To ensure patient compliance.
 To avoid medical errors.
 To exploit advances in knowledge made by
pharmacologists.
Rational Use of Medicine
 The rational use of medicines results into a
more effective treatment at an affordable cost.
 WHO defines rational use of medicines as
"Patients receive medications appropriate
to their clinical needs, in doses that meet
their own individual requirements, for an
adequate period of time, and at the lowest
cost to them and their community"
 As per the Standard Treatment Protocol,
Public Health Department, Government of
Maharashtra, throughout the world, more than
50% of all medicines are prescribed
dispensed, or sold inappropriately, while 50%
of patients fail to take them correctly.
Moreover, about one-third of the world's
population lacks access to essential
medicines.
 Some examples of irrational use of medicines
are: 1. Polypharmacy that is the use of at least
five drugs daily by an individual.
2. Inappropriate use of antibiotics, often in
inadequate dosage
3. Use of antibacterial antibiotics for viral
infections
4 Inappropriate self-medication, often for
prescription-only medicines.
5. Over-use of parenterals when oral
formulations would be more appropriate
 Reasons for irrational use of medicines are
 Lack of sufficient information
 Faulty and inadequate training and education of
health professionals
 No proper communication between health
professionals and patients
 Confusion about diagnosis
 Demand from the patient.
 Defective drug supply system.
 Ineffective drug regulation.
 Promotional activities of pharmaceutical
 Factors leading to need for rational use of medicines are:
 Drug explosion: Availability of number of medicines for a
particular disease complicates selection of appropriate
drug.
 Drug resistance: Irrational use of medicine may lead
development of resistance highly effective drugs to highly
effective drugs.
 Easy availability of drug information: With the rapid
spread of internet and mobile technology, information
about drug development, its uses and adverse effects can
be accessed by any part of the world and is available at
the fingertips of consumers
 Increased treatment cost: Rational use of medicine can
reduce the treatment cost and thus reduce economic
burden on the public as well as on the Government
 Consumer Protection Act (CPA): Extension of consumer
protection act in medical profession may restrict the
irrational use of medicines.
WHO defines rational use of medicines as
"Patients receive medications appropriate
to their clinical needs, in doses that meet
their own individual requirements, for an
adequate period of time, and at the lowest
cost to them and their community.”
Evidence Based Medicine
 Evidence based medicine (LBM) can be
defined as the "Systematic approach to
clinical problem solving which allows the
integration of the best available research
evidence with clinical expertise and patient
values".
 Clinical expertise is the knowledge, experience
and clinical skill of the doctor Patient values
are individual characteristics, such as gender,
race/ethnicity, socioeconomic status and
emotional status that may influence a patient's
health, age and wellness
 Evidence based medicine is a systematic
approach to medicine in which doctors and
other healthcare professionals use the
current, best scientific evidence from
clinical research to make decisions about
the care of individual patients.
Significance of Evidence Based
Medicine
 The use of EBM is crucial in maintaining quality
medical care and ensuring good clinical
outcomes.
 It provides cost effective medical care.
 It promotes consistency of treatment and optimal
outcomes.
 It helps to establish national standards of patient
care.
 It keeps doctors and other healthcare professional
updated.
 It identifies and promotes practices that work, and
eliminates those that are ineffective or harmful.
 Clinical Pharmacology is the scientific study of
drugs in man and woman.
 The aim of clinical pharmacology is to
generate data for optimum use of drugs and
the practice of evidence based medicine.
 The randomized controlled clinical trial is
considered to provide the most reliable
evidence on the effectiveness of a drug.
 Evidence based Medicine is dependant upon
wide availability and coverage of accurate
systematic reviews and meta-analysis of
clinical studies.
 A physician’s clinical experience and patient’s
values and preferences play important role in
the process of using the evidence to make
decisions. The practice of evidence based
medicine involves five essential steps:
 Converting information needs into answerable
questions.
 Finding the best evidence with which to
answer the questions.
 Critically appraising the evidence for its validity
and usefulness.
 Applying the results of appraisal into clinical
practice.
 Evaluating performance.
Essential Medicine List
 WHO defines EML as the medicines that
satisfy the priority healthcare needs of the
population.
 EML is prepared by considering:
 Disease prevalence
 Efficacy of medicines
 Safety of medicines
 Comparative cost effectiveness of medicines
 Easy availability of medicines
 The drugs from essential medicine list are
intended to be available in adequate amounts,
in appropriate dosage forms and strengths
with assured quality and adequate information,
and at an affordable price.
 The list of essential medicines needs to be
updated/revised periodically. The updated
WHO List of Essential Medicines and List of
Essential Medicines for Children are published
every two years.
History of the Essential Medicines List:
 In 1970, Tanzania became the first country to
prepare its EML Subsequently, the first WHO model
list of essential medicines was published in the year
1977 which contained 186 medicines.
 The latest WHO model list of essential medicines is
22 list published in 2021 The Ministry of Health and
Family Welfare, Government of India prepared and
released the first National List of Essential Medicines
(NLEM) of India in 1996 consisting of 279 medicines.
 This list was subsequently revised in 2003 containing
354 medicines, 2011containing 348 medicines, 2015
containing 376 medicines and now in 2021
containing 399 medicines.
Advantages of Essential Medicines List:
 An essential medicines list (EML) results in better
quality of medical care, better management of
medicines and cost-effective use of healthcare
resources.
 The essential medicines list has a positive impact
on the availability and rational use of medicines.
 The essential medicines list can be used as
guidelines for the procurement and supply of
medicines in public sector, schemes for
reimbursement of drug costs and local drug
production.
 In hospitals, it improves the quality of prescribing
Selection of Essential Medicines: The following
factors are considered for selection of essential
medicines:
 Incidence and prevalence of disease (public health
relevance)
 Efficacy, safety, and comparative cost effectiveness
of available medicines (price oftotal treatment is
considered and not the unit price of a medicine)
 The medicine should be aligned with the current
treatment guidelines for the disease
 Level of healthcare facility available.
 Treatment facilities available
 Training and experience of the available personnel
 Local availability of individual drugs
 Available financial resources
National List of Essential Medicines
(NLEM):
 ICMR under Ministry of Health and Family
Welfare, Government of India revises and
publishes NLEM in India. Essential medicines
in NLEM have been marked into three
categories for being available at primary,
secondary and tertiary levels of health care
facility.
Purpose of the National List of Essential
Medicines:
 Guide safe and effective treatment of priority
disease conditions of a population.
 Promote the rational use of medicines
 Optimize the available health resources
It is also a guiding document for:
a) State governments to prepare their list of
essential medicines
b) Procurement and supply of medicines in the
public sector
c) Reimbursement of cost of medicines by
organizations to its employees
STANDARD TREATMENT
GUIDELINES
 Standard treatment guidelines are also known as
standard treatment protocols (STP) standard
treatment schedules, therapeutic guidelines and
prescribing policies.
 These include the preferred pharmaceutical and
non-pharmaceutical treatments for common
health problems came across by people in a
specific health system.
 These guidelines usually represent one of the
approaches to promote therapeutically effective
and economically efficient use of medicines
 Purpose and Content of Standard Treatment
Guideline (STG):
 An effectively implemented guideline (STG) is
advantageous for beneficiaries, healthcare
providers supply managers and health policy
makers.
 As we know improper use or misuse of medicines
in the treatment of any medical condition is
extensive which is harmful for people.
 The idea behind having STG is to have
standardization in terms of treatment and promote
effective and efficient treatment options STG may
be used at different stages of the therapeutic
process.
 It could include medical supplies as also following
prescribed treatments. It could assist in better
Advantages of Standard Treatment Guidelines:
 Provides standardized guidance to practitioners
 Provides the most effective therapy in terms of
quality
 Encourages practitioners for high quality care
 The healthcare system needs to provide only the
medicines as per formulary or list of essential
medicines
 Provides valuable assistance to all practitioners,
especially to those with lower level skills
 Enables healthcare providers to concentrate on
making the correct diagnosis becausetreatment
options are available for them in the form of STG
 Provides a basis for evaluating quality of care
Some of the standard treatment guidelines available in
India are:
 Hypertension: Screening. Diagnosis Assessment, and
Management of Primary Hypertension in Adults in India,
AUGUST 2017, Ministry of Health and Family Welfare,
Government of India
 Treatment Guidelines for Antimicrobial Use in Common
Syndromes. 2 edition Publications of the ICMR, New Delhi
 Guidelines for Programmatic Management of Drug Resistant
TB (PMDT)in India, March 2021, National TB Elimination
Programme. Central TB Division, Ministry of Health and
Family Welfare, Government of India, New Delhi.
 National Guidelines for Clinical Management of Dengue
Fever. National Vector Borne Disease Control Programme
WHO, 2015
 Standard Treatment Protocol Public Health Department
Government of Maharashtra
 Standard Treatment Guidelines. A Manual for Medical
Therapeutics, First Edition 2014 Gujarat Medical Services
Corporation Ltd. Health and Family Welfare Department,
Government of Gujarat.
 Standard Treatment Guidelines (2016). Department of Public
Introduction_Pharmacotherapeutics.pptx

More Related Content

Similar to Introduction_Pharmacotherapeutics.pptx

RATIONAL DRUG USE
RATIONAL DRUG USERATIONAL DRUG USE
RATIONAL DRUG USE
sarvajeetkhare
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
maneeshkumar reddy
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
Adhin Antony Xavier
 
Concept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugsConcept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugs
Nilayan Guha
 
An introduction to medication therapy management
An introduction to medication therapy managementAn introduction to medication therapy management
An introduction to medication therapy management
Kabito Kiwanuka
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
AjithJs2
 
L1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdfL1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdf
swr88kv5p2
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptx
arslan8262
 
Rational drug use
Rational drug useRational drug use
Rational drug use
Farzana Sultana
 
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
Dr Jeenal Mistry
 
Clinical pharmacy recent advances
Clinical pharmacy recent advances Clinical pharmacy recent advances
Clinical pharmacy recent advances
manik chhabra.
 
Edl ppt
Edl pptEdl ppt
Edl ppt
aishuanju
 
Prescription auditing
Prescription auditingPrescription auditing
Prescription auditing
Sumit Kumar
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
Mmedsc Hahm
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.
Mdshams244
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
Ahmad Ali
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
SriramNagarajan16
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
Naser Tadvi
 

Similar to Introduction_Pharmacotherapeutics.pptx (20)

RATIONAL DRUG USE
RATIONAL DRUG USERATIONAL DRUG USE
RATIONAL DRUG USE
 
Drug Therapy Monitiring
Drug Therapy MonitiringDrug Therapy Monitiring
Drug Therapy Monitiring
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
 
Concept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugsConcept of essential drugs and rational use of drugs
Concept of essential drugs and rational use of drugs
 
An introduction to medication therapy management
An introduction to medication therapy managementAn introduction to medication therapy management
An introduction to medication therapy management
 
clinical pharmacy .pptx
clinical pharmacy .pptxclinical pharmacy .pptx
clinical pharmacy .pptx
 
Essential drug list
Essential drug listEssential drug list
Essential drug list
 
L1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdfL1 pharmacotherapy introduction ……...pdf
L1 pharmacotherapy introduction ……...pdf
 
Pharmacist care services.pptx
Pharmacist care services.pptxPharmacist care services.pptx
Pharmacist care services.pptx
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
Rational Use of Medicine_Evidence Based Medicine_Therapeutic Drug Monitoring_...
 
research 1
research 1research 1
research 1
 
Clinical pharmacy recent advances
Clinical pharmacy recent advances Clinical pharmacy recent advances
Clinical pharmacy recent advances
 
Edl ppt
Edl pptEdl ppt
Edl ppt
 
Prescription auditing
Prescription auditingPrescription auditing
Prescription auditing
 
Concepts of em
Concepts of emConcepts of em
Concepts of em
 
Rational drug therapy A.R.S.
Rational drug therapy A.R.S.Rational drug therapy A.R.S.
Rational drug therapy A.R.S.
 
Pharmacoepidemiology (2)
Pharmacoepidemiology (2)Pharmacoepidemiology (2)
Pharmacoepidemiology (2)
 
A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...A study on prescription pattern and rational use of statins in tertiary care ...
A study on prescription pattern and rational use of statins in tertiary care ...
 
Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance Pharmacoeconomics & drug compliance
Pharmacoeconomics & drug compliance
 

More from Dr. Kiran Dhamak

Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Dr. Kiran Dhamak
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Dr. Kiran Dhamak
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Dr. Kiran Dhamak
 
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in PharmacyDermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dr. Kiran Dhamak
 
3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx
Dr. Kiran Dhamak
 
3.4 Dental products.pptx
3.4 Dental products.pptx3.4 Dental products.pptx
3.4 Dental products.pptx
Dr. Kiran Dhamak
 
3.2 Antacids.pptx
3.2 Antacids.pptx3.2 Antacids.pptx
3.2 Antacids.pptx
Dr. Kiran Dhamak
 
3.1 Haematinics.pptx
3.1 Haematinics.pptx3.1 Haematinics.pptx
3.1 Haematinics.pptx
Dr. Kiran Dhamak
 
4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx
Dr. Kiran Dhamak
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
Dr. Kiran Dhamak
 
Psychiatric_Disorder.pptx
Psychiatric_Disorder.pptxPsychiatric_Disorder.pptx
Psychiatric_Disorder.pptx
Dr. Kiran Dhamak
 

More from Dr. Kiran Dhamak (11)

Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
Central Nervous System, Epilepsy, Parkinson, Alzheimer, Stroke and Migraine.
 
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
Gastrointestinal_Disorder.pptx, GERD, Peptic Ulcer Diseases, Inflammatory Bow...
 
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. PharmCardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
Cardiovascular_System, Pharmacotherapeutics, Second Year D. Pharm
 
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in PharmacyDermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
Dermatology. Second Year D. Pharmacy, PCI Syllabus, Diploma in Pharmacy
 
3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx3.3 Antimicrobial Agents.pptx
3.3 Antimicrobial Agents.pptx
 
3.4 Dental products.pptx
3.4 Dental products.pptx3.4 Dental products.pptx
3.4 Dental products.pptx
 
3.2 Antacids.pptx
3.2 Antacids.pptx3.2 Antacids.pptx
3.2 Antacids.pptx
 
3.1 Haematinics.pptx
3.1 Haematinics.pptx3.1 Haematinics.pptx
3.1 Haematinics.pptx
 
4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx4. Heterocyclic_Compounds.pptx
4. Heterocyclic_Compounds.pptx
 
Antimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptxAntimicrobial_Resistance.pptx
Antimicrobial_Resistance.pptx
 
Psychiatric_Disorder.pptx
Psychiatric_Disorder.pptxPsychiatric_Disorder.pptx
Psychiatric_Disorder.pptx
 

Recently uploaded

CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 

Recently uploaded (20)

CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 

Introduction_Pharmacotherapeutics.pptx

  • 2. Learning Objectives  After studying the chapter, students will be able to  Understand the concept of Pharmacotherapeutics  Explain rational use of medicine  Understand the concept of evidence based medicine  Use essential medicines list  Understand the concept of standard treatment guidelines  Assess their knowledge and understand the chapter through practice questions
  • 3. Introduction  Pharmacotherapeutics is a branch of Pharmacology.  It is the study of therapeutic uses and effects of drugs.  It is the application of pharmacological information of drugs to prevent mitigate treat and diagnose diseases as well as to change normal functions (such as contraception).  It includes determination of therapeutic objectives selection of the most appropriate drug, route of administration, dosage and duration of treatment considering.
  • 4. Pharmacotherapeutics is the study of therapeutic uses and effects of drugs.  Stage of disease  The patient's current drugs  Pharmacokinetics of drugs  Contraindications  Adverse effects of drugs  The specific features of a patient
  • 5.  Only Rational Pharmacotherapy brings good treatment results.  Rational pharmacotherapy means that medications are prescribed sensibly delivered correctly and that the patient is given the required information about taking them.  Knowledge of pharmacotherapy is essential to practice medicine.  Appropriate pharmacotherapy helps patients to maintain their functional capacity and reduce the costs to both patients and society.  The other forms of therapies to treat diseases are surgical therapy, physical therapy, radiation therapy, etc
  • 6. Scope  The study of Pharmacotherapeutics imparts knowledge and skills necessary to contribution to quality use of medicines.  Pharmacotherapy focuses on the relationship between drugs and their safe and efficient use to humans.  It ensures proper and rational use of drugs.  Determination of therapeutic objectives, selection of the most appropriate drug dosage and duration of treatment considering the stage of disease and the specific feature of a patient are a part of pharmacotherapeutics
  • 7. Objectives  The main objective of pharmacotherapeutics is to enhance the safety of prescription maximize the effects of drugs and to minimize side effects.  To prepare individualized therapeutic plans based on diagnosis  To achieve defined therapeutic goals to improve a patient's quality of life while minimizing harm.  To maintain drug therapy costs at an optimum level and still provide quality and effective treatment  To ensure patient compliance.  To avoid medical errors.  To exploit advances in knowledge made by pharmacologists.
  • 8. Rational Use of Medicine  The rational use of medicines results into a more effective treatment at an affordable cost.  WHO defines rational use of medicines as "Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community"
  • 9.  As per the Standard Treatment Protocol, Public Health Department, Government of Maharashtra, throughout the world, more than 50% of all medicines are prescribed dispensed, or sold inappropriately, while 50% of patients fail to take them correctly. Moreover, about one-third of the world's population lacks access to essential medicines.
  • 10.  Some examples of irrational use of medicines are: 1. Polypharmacy that is the use of at least five drugs daily by an individual. 2. Inappropriate use of antibiotics, often in inadequate dosage 3. Use of antibacterial antibiotics for viral infections 4 Inappropriate self-medication, often for prescription-only medicines. 5. Over-use of parenterals when oral formulations would be more appropriate
  • 11.  Reasons for irrational use of medicines are  Lack of sufficient information  Faulty and inadequate training and education of health professionals  No proper communication between health professionals and patients  Confusion about diagnosis  Demand from the patient.  Defective drug supply system.  Ineffective drug regulation.  Promotional activities of pharmaceutical
  • 12.  Factors leading to need for rational use of medicines are:  Drug explosion: Availability of number of medicines for a particular disease complicates selection of appropriate drug.  Drug resistance: Irrational use of medicine may lead development of resistance highly effective drugs to highly effective drugs.  Easy availability of drug information: With the rapid spread of internet and mobile technology, information about drug development, its uses and adverse effects can be accessed by any part of the world and is available at the fingertips of consumers  Increased treatment cost: Rational use of medicine can reduce the treatment cost and thus reduce economic burden on the public as well as on the Government  Consumer Protection Act (CPA): Extension of consumer protection act in medical profession may restrict the irrational use of medicines.
  • 13. WHO defines rational use of medicines as "Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community.”
  • 14. Evidence Based Medicine  Evidence based medicine (LBM) can be defined as the "Systematic approach to clinical problem solving which allows the integration of the best available research evidence with clinical expertise and patient values".
  • 15.  Clinical expertise is the knowledge, experience and clinical skill of the doctor Patient values are individual characteristics, such as gender, race/ethnicity, socioeconomic status and emotional status that may influence a patient's health, age and wellness
  • 16.  Evidence based medicine is a systematic approach to medicine in which doctors and other healthcare professionals use the current, best scientific evidence from clinical research to make decisions about the care of individual patients.
  • 17. Significance of Evidence Based Medicine  The use of EBM is crucial in maintaining quality medical care and ensuring good clinical outcomes.  It provides cost effective medical care.  It promotes consistency of treatment and optimal outcomes.  It helps to establish national standards of patient care.  It keeps doctors and other healthcare professional updated.  It identifies and promotes practices that work, and eliminates those that are ineffective or harmful.
  • 18.  Clinical Pharmacology is the scientific study of drugs in man and woman.  The aim of clinical pharmacology is to generate data for optimum use of drugs and the practice of evidence based medicine.  The randomized controlled clinical trial is considered to provide the most reliable evidence on the effectiveness of a drug.
  • 19.  Evidence based Medicine is dependant upon wide availability and coverage of accurate systematic reviews and meta-analysis of clinical studies.  A physician’s clinical experience and patient’s values and preferences play important role in the process of using the evidence to make decisions. The practice of evidence based medicine involves five essential steps:
  • 20.  Converting information needs into answerable questions.  Finding the best evidence with which to answer the questions.  Critically appraising the evidence for its validity and usefulness.  Applying the results of appraisal into clinical practice.  Evaluating performance.
  • 21. Essential Medicine List  WHO defines EML as the medicines that satisfy the priority healthcare needs of the population.  EML is prepared by considering:  Disease prevalence  Efficacy of medicines  Safety of medicines  Comparative cost effectiveness of medicines  Easy availability of medicines
  • 22.  The drugs from essential medicine list are intended to be available in adequate amounts, in appropriate dosage forms and strengths with assured quality and adequate information, and at an affordable price.  The list of essential medicines needs to be updated/revised periodically. The updated WHO List of Essential Medicines and List of Essential Medicines for Children are published every two years.
  • 23. History of the Essential Medicines List:  In 1970, Tanzania became the first country to prepare its EML Subsequently, the first WHO model list of essential medicines was published in the year 1977 which contained 186 medicines.  The latest WHO model list of essential medicines is 22 list published in 2021 The Ministry of Health and Family Welfare, Government of India prepared and released the first National List of Essential Medicines (NLEM) of India in 1996 consisting of 279 medicines.  This list was subsequently revised in 2003 containing 354 medicines, 2011containing 348 medicines, 2015 containing 376 medicines and now in 2021 containing 399 medicines.
  • 24. Advantages of Essential Medicines List:  An essential medicines list (EML) results in better quality of medical care, better management of medicines and cost-effective use of healthcare resources.  The essential medicines list has a positive impact on the availability and rational use of medicines.  The essential medicines list can be used as guidelines for the procurement and supply of medicines in public sector, schemes for reimbursement of drug costs and local drug production.  In hospitals, it improves the quality of prescribing
  • 25. Selection of Essential Medicines: The following factors are considered for selection of essential medicines:  Incidence and prevalence of disease (public health relevance)  Efficacy, safety, and comparative cost effectiveness of available medicines (price oftotal treatment is considered and not the unit price of a medicine)  The medicine should be aligned with the current treatment guidelines for the disease  Level of healthcare facility available.  Treatment facilities available  Training and experience of the available personnel  Local availability of individual drugs  Available financial resources
  • 26. National List of Essential Medicines (NLEM):  ICMR under Ministry of Health and Family Welfare, Government of India revises and publishes NLEM in India. Essential medicines in NLEM have been marked into three categories for being available at primary, secondary and tertiary levels of health care facility.
  • 27. Purpose of the National List of Essential Medicines:  Guide safe and effective treatment of priority disease conditions of a population.  Promote the rational use of medicines  Optimize the available health resources It is also a guiding document for: a) State governments to prepare their list of essential medicines b) Procurement and supply of medicines in the public sector c) Reimbursement of cost of medicines by organizations to its employees
  • 28. STANDARD TREATMENT GUIDELINES  Standard treatment guidelines are also known as standard treatment protocols (STP) standard treatment schedules, therapeutic guidelines and prescribing policies.  These include the preferred pharmaceutical and non-pharmaceutical treatments for common health problems came across by people in a specific health system.  These guidelines usually represent one of the approaches to promote therapeutically effective and economically efficient use of medicines
  • 29.  Purpose and Content of Standard Treatment Guideline (STG):  An effectively implemented guideline (STG) is advantageous for beneficiaries, healthcare providers supply managers and health policy makers.  As we know improper use or misuse of medicines in the treatment of any medical condition is extensive which is harmful for people.  The idea behind having STG is to have standardization in terms of treatment and promote effective and efficient treatment options STG may be used at different stages of the therapeutic process.  It could include medical supplies as also following prescribed treatments. It could assist in better
  • 30. Advantages of Standard Treatment Guidelines:  Provides standardized guidance to practitioners  Provides the most effective therapy in terms of quality  Encourages practitioners for high quality care  The healthcare system needs to provide only the medicines as per formulary or list of essential medicines  Provides valuable assistance to all practitioners, especially to those with lower level skills  Enables healthcare providers to concentrate on making the correct diagnosis becausetreatment options are available for them in the form of STG  Provides a basis for evaluating quality of care
  • 31. Some of the standard treatment guidelines available in India are:  Hypertension: Screening. Diagnosis Assessment, and Management of Primary Hypertension in Adults in India, AUGUST 2017, Ministry of Health and Family Welfare, Government of India  Treatment Guidelines for Antimicrobial Use in Common Syndromes. 2 edition Publications of the ICMR, New Delhi  Guidelines for Programmatic Management of Drug Resistant TB (PMDT)in India, March 2021, National TB Elimination Programme. Central TB Division, Ministry of Health and Family Welfare, Government of India, New Delhi.  National Guidelines for Clinical Management of Dengue Fever. National Vector Borne Disease Control Programme WHO, 2015  Standard Treatment Protocol Public Health Department Government of Maharashtra  Standard Treatment Guidelines. A Manual for Medical Therapeutics, First Edition 2014 Gujarat Medical Services Corporation Ltd. Health and Family Welfare Department, Government of Gujarat.  Standard Treatment Guidelines (2016). Department of Public